Fisher & Paykel Healthcare Corporation Limited Share Price

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E. 23:00:00 28/05/2024 BST 5-day change 1st Jan Change
28.75 NZD +3.94% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +0.45% +21.82%

Financials

Sales 2025 * 1.95B 1.2B 94.03B Sales 2026 * 2.17B 1.33B 104B Capitalization 16.64B 10.2B 801B
Net income 2025 * 338M 207M 16.26B Net income 2026 * 405M 248M 19.48B EV / Sales 2025 * 8.55 x
Net Debt 2025 * 77.32M 47.37M 3.72B Net Debt 2026 * 88.34M 54.12M 4.25B EV / Sales 2026 * 7.72 x
P/E ratio 2025 *
49.5 x
P/E ratio 2026 *
41.1 x
Employees 7,005
Yield 2025 *
1.52%
Yield 2026 *
1.7%
Free-Float 90.59%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 day+3.94%
1 week+0.45%
Current month+0.98%
1 month+2.72%
3 months+17.35%
6 months+20.80%
Current year+21.82%
More quotes
1 week
27.51
Extreme 27.51
29.73
1 month
27.51
Extreme 27.51
29.73
Current year
22.55
Extreme 22.55
29.73
1 year
20.29
Extreme 20.29
29.73
3 years
18.02
Extreme 18.02
34.55
5 years
14.85
Extreme 14.85
37.89
10 years
4.43
Extreme 4.43
37.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 31/12/84
Director of Finance/CFO - 28/02/19
Chief Tech/Sci/R&D Officer - 31/07/14
Members of the board TitleAgeSince
Director/Board Member 66 30/04/90
Chairman - 30/09/15
Chief Executive Officer 63 31/12/84
More insiders
Date Price Change Volume
29/05/24 28.75 +3.94% 657,795
28/05/24 27.66 -1.39% 286,642
27/05/24 28.05 -0.99% 107,346
24/05/24 28.33 -0.56% 400,308
23/05/24 28.49 -0.45% 294,477

End-of-day quote New Zealand S.E., May 28, 2024

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
28.75 NZD
Average target price
25.83 NZD
Spread / Average Target
-10.14%
Consensus